Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Retained Earnings (2016 - 2017)

Bone Biologics has reported Retained Earnings over the past 3 years, most recently at -$59.2 million for Q4 2017.

  • Quarterly Retained Earnings fell 13.53% to -$59.2 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was -$59.2 million through Dec 2017, down 13.53% year-over-year, with the annual reading at -$59.2 million for FY2017, 13.53% down from the prior year.
  • Retained Earnings was -$59.2 million for Q4 2017 at Bone Biologics, down from $56.4 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $56.4 million in Q3 2017 and troughed at -$59.2 million in Q4 2017.
  • The 3-year median for Retained Earnings is $43.2 million (2016), against an average of $20.4 million.
  • Year-over-year, Retained Earnings tumbled 15436.48% in 2016 and then soared 42.93% in 2017.
  • A 3-year view of Retained Earnings shows it stood at $339931.0 in 2015, then tumbled by 15436.48% to -$52.1 million in 2016, then fell by 13.53% to -$59.2 million in 2017.
  • Per Business Quant, the three most recent readings for BBLG's Retained Earnings are -$59.2 million (Q4 2017), $56.4 million (Q3 2017), and $54.0 million (Q2 2017).